Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.
OBJECTIVE
There is an increased risk of renal cell carcinoma (RCC) in human diabetes mellitus. We therefore examined the influence of hyperglycaemia and glucose-lowering treatment on nephrocarcinogenesis in rats.


METHODS
Rats (n = 850), which were either spontaneously diabetic, streptozotocin-diabetic or normoglycaemic, were examined with special reference to Armanni-Ebstein lesions (AEL).


RESULTS
Irrespective of the cause of diabetes, diabetic but not normoglycaemic rats developed typical glycogenotic clear-cell AEL. AEL showed strong proliferative activity, which was nearly completely inhibited by EGF receptor blockade (Gefitinib treatment). Many findings suggested a stepwise development of RCCs from AEL. Whereas the number and size of RCCs gradually increased in all diabetic groups, beginning at 6 months after onset of diabetes, normoglycaemic controls did not developed RCC. After 28 months, up to 82% of diabetic animals had at least one RCC. In contrast to the proximal tubules, the distal tubular system, including glycogenotic AEL, had the same levels of enzyme activities as RCC (e.g. high glycogen phosphorylase and synthase activity, lack of glucose 6-phosphatase activity) and the same expression patterns of cytokeratin 7 and several growth factors, along with their receptors and signal transduction proteins (TGF-alpha, EGF receptor, IGF-I, IGF-I receptor, IGF-II receptor, insulin receptor substrate 1, v-raf-1 murine leukemia viral oncogene homologue 1 and mitogen activated protein kinase kinase 1). In addition, direct morphological transitions between distal tubules, AEL and RCCs were frequently observed. All these findings indicate a common origin and a precursor-product relationship of AEL and RCCs.


CONCLUSIONS
Nephrocarcinogenesis in diabetic rats results from sustained hyperglycaemia, resulting in an adaptive metabolic response, altered growth factor signalling and subsequent neoplastic transformation of the tubular epithelial cells.
Dombrowski
F
F
Institut für Pathologie, Ernst-Moritz-Arndt-Universität Greifswald, Friedrich-Loeffler-Strasse 23e, 17487, Greifswald, Germany. frank.dombrowski@uni-greifswald.de
Klotz
L
L
Bannasch
P
P
Evert
M
M
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000201:enzymology / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D049109:Cell Proliferation; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000201:enzymology / Q000378:metabolism*; D004195:Disease Models, Animal; D018450:Disease Progression; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D053552:Keratin-7 / Q000378:metabolism; D007668:Kidney / Q000473:pathology; D007680:Kidney Neoplasms / Q000201:enzymology / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D008297:Male; D011230:Precancerous Conditions / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D051381:Rats; D011917:Rats, Inbred Lew; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction; D013311:Streptozocin; D013997:Time Factors
D036341:Intercellular Signaling Peptides and Proteins; D053552:Keratin-7; D013311:Streptozocin